±è´ë½Ä

  • Áø·á°ú

    Ç÷¾×³»°ú

  • Àü¹®Áø·áºÐ¾ß

    ¸²ÇÁÁ¾, ´Ù¹ß°ñ¼öÁ¾, Ç÷¾×Áúȯ, Á¶Ç÷¸ð¼¼Æ÷À̽Ä

  • ´ã´çŬ¸®´Ð

  • °ü·Ã¼¾ÅÍ

    Ç÷¾×¾Ï ¼¾ÅÍ

±è´ë½Ä

±è´ë½Ä ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
Ç÷¾×³»°ú
¿ÀÀü
¿ÀÈÄ
¿ÀÈÄ
¿ÀÀü
- - ¸²ÇÁÁ¾, ´Ù¹ß°ñ¼öÁ¾, Ç÷¾×Áúȯ, Á¶Ç÷¸ð¼¼Æ÷À̽Ä

±è´ë½Ä ±³¼öÀÇ »ó¼¼Á¤º¸

ÇÐȸȰµ¿

  •  ~   :  ´ëÇÑÀÇ»çÇùȸ, ȸ¿ø
  •  ~   :  ´ëÇѳ»°úÇÐȸ, ȸ¿ø
  •  ~   :  ´ëÇÑÇ÷¾×ÇÐȸ, ȸ¿ø
  •  ~   :  ´ëÇÑÇ÷¾×ÇÐȸ, Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ¿î¿µÀ§¿ø
  •  ~   :  ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ, ȸ¿ø
  •  ~   :  ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ, ÀÓ»ó½ÃÇèÀ§¿øȸ ¿î¿µÀ§¿ø
  •  ~   :  ´ëÇѾÏÇÐȸ, ȸ¿ø
  •  ~   :  Çѱ¹ÀÓ»ó¾ÏÇÐȸ, ȸ¿ø
  •  ~   :  ´ëÇÑÇ׾Ͽä¹ý¿¬±¸È¸, ȸ¿ø

±¹³»È°µ¿

  •  ~  2015  :  Kim DS, Kang KW, Park Y et al, Chemomobilization strategies with intermediate-dose etoposide and delayed use of G-CSF for autologous stem cell transplantation in patients with hematologic malignancies: high effectiveness and delayed platelet recovery. 2015, The 19th Winter Meeting of the Korean Society of Blood and Marrow Transplantation Oral presentation
  •  ~  2014  :  Kim DS, Na YJ, Kang MH, et al. Deferasirox, Iron chelator to overcome imatinib resistance in chronic myeloid leukemia cells, 2014, The 55th Autumn Meeting of the Korean Society of Hematology Oral presentation
  •  ~  2012  :  Kim DS, Park Y, Choi CW et al. The Results of Chemotherapy for the Elderly Acute Myelogenous Leukemia Patients. 2012, The 53rd Spring Meeting of the Korean Society of Hematology Oral presentation
  •  ~  2012  :  Kim DS, Kim JL, Choi CW et at. Inhibition of Hedgehog Pathway in Myeloid Leukemia Cells. 2012, The 53rd Spring Meeting of the Korean Society of Hematology Oral presentation
  •  ~  2013  :  Kim DS, Kim JL, Choi CW et at Combination effect of hedgehog inhibitor and iron chelator in myeloid leukemia cells. 2013, The 54th Spring Meeting of the Korean Society of Hematology Oral presentation

±¹¿ÜÈ°µ¿

  •  ~  2017  :  Kim DS, Jung SH, Shin HJ et al. Upfront autologous stem cell transplantation in patients with diffuse large B cell lymphoma: focused on risk factors for survival and conditioning regimen. 2017 The 43rd Annual Meeting of the European Society for Blood and Marrow Transplantation Poster presentation
  •  ~   :  Kang KW, Kim DS, Park Y et al. Routine Imaging for Surveillance in Patients with Aggressive Non-Hodgkin Lymphoma in Complete Remission after Frontline Chemotherapy. The 58th American Society of Hematology Annual Meeting and Exposition Poster presentation
  •  ~  2015  :  Kim DS, Kang KW, Park Y et al. Chemomobilization strategies with intermediate-dose etoposide and delayed use of G-CSF for autologous stem cell transplantation in patients with hematologic malignancies: high effectiveness and delayed platelet recovery. 2015 The 41st Annual Meeting of the European Society for Blood and Marrow Transplantation Poster presentation
  •  ~  2013  :  Kim DS, Kang KW, Park Y et al. High-Dose Cytarabine Consolidation (¡Ã1.5/m2) Might Have Shown a Better Outcomes Than Intermediate-dose Cytarabine (1.0g/m2) Combined With Anthracyclines In AML Patients Who Had Achieved Complete Remissions In The First Induction by Standard 3+7 Regimen. 2013, The 55th American Society of Hematology Annual Meeting and Exposition Poster presentation

ÃÖÁ¾¼öÁ¤ÀÏ : 2023.05.08